AVE vs PYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

53MEDIUM

PYC

PYC THERAP FPO [PYC]

53MEDIUM

Score Breakdown

AVE PYC
Technical
52
60
Catalyst
62
55
Sentiment
50
50
Fundamental
49
42
Momentum
75
75
Risk Gate
45
50

Key Metrics

AVE Metric PYC
$77.3MMarket Cap$1.5B
24.9MAvg Volume (20d)1.1M
N/AShort Interest+0.3%
$0.02752-Week High$1.755
$0.00452-Week Low$0.848
-2.4%Daily Change-1.3%
$0.020Entry Price$1.530
-182.9%ROE-47.5%
N/AProfit Margin-231.3%

Active Signals

AVE Signals

●MACD momentum is losing steam
●Beating the Small Ords index — relative strength of 1.65, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Very high P/S ratio (62.4x)
●Revenue in sharp decline (-17%)
●Small-cap ($20-100M)
●Not enough chatter to gauge sentiment — defaulting to neutral

PYC Signals

●MACD momentum is losing steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Very high P/S ratio (74.1x)
●Revenue in sharp decline (-25%)
●Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare AVE and PYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
AVE Full Analysis → PYC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).